Low frequency of drug-resistant virus did not affect the therapeutic efficacy in daclatasvir plus asunaprevir therapy in patients with chronic HCV genotype-1 infection.
第一作者:
Hideaki,Kinugasa
第一单位:
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
作者:
主题词
成年人(Adult);老年人(Aged);氨基酸取代(Amino Acid Substitution);抗病毒药(Antiviral Agents);氨甲酸酯类(Carbamates);抗药性, 病毒(Drug Resistance, Viral);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);基因型(Genotype);肝炎病毒属(Hepacivirus);丙型肝炎, 慢性(Hepatitis C, Chronic);人类(Humans);咪唑类(Imidazoles);异喹啉类(Isoquinolines);男(雄)性(Male);中年人(Middle Aged);多态性, 单核苷酸(Polymorphism, Single Nucleotide);吡咯烷类(Pyrrolidines);再治疗(Retreatment);磺胺类(Sulfonamides);时间因素(Time Factors);治疗失败(Treatment Failure);治疗结果(Treatment Outcome);缬氨酸(Valine);病毒载量(Viral Load);病毒非结构蛋白质类(Viral Nonstructural Proteins)
DOI
10.3851/IMP2976
PMID
26115551
发布时间
2021-12-03
- 浏览21

Antiviral therapy
37-44页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文